UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052869
Receipt number R000060332
Scientific Title Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases
Date of disclosure of the study information 2023/12/01
Last modified on 2023/11/22 13:37:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Acronym

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Scientific Title

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Scientific Title:Acronym

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Region

Japan


Condition

Condition

Parkison's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To descriptively analyze the adherence and persistence of newly initiated Parkinson's disease medication in patients with Parkinson's disease receiving oral levodopa treatment

Basic objectives2

Others

Basic objectives -Others

Pharmacoepidemiology

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

1) Treatment adherence, and
2) Treatment persistence
during 1-year follow-up period

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with Parkinson's disease receiving oral levodopa treatment who began taking an additional Parkinson's disease medication

Key exclusion criteria

Patients with a diagnosis of a disease that requires differentiation from Parkinson's disease

Target sample size

10000


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Ishida

Organization

Eisai Co., Ltd.

Division name

Medical HQs

Zip code

112-8088

Address

Koishikawa 4-6-10, Bunkyo-ku, Tokyo

TEL

070-3762-8613

Email

t8-ishida@hhc.eisai.co.jp


Public contact

Name of contact person

1st name Michinori
Middle name
Last name Koebisu

Organization

Eisai Co., Ltd.

Division name

Medical HQs

Zip code

112-8088

Address

Koishikawa 4-6-10, Bunkyo-ku, Tokyo

TEL

070-7536-2306

Homepage URL


Email

m-koebisu@hhc.eisai.co.jp


Sponsor or person

Institute

Eisai Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board,Ehime University Hospital

Address

454 Shitsukawa, Toon, Ehime

Tel

089-960-5172

Email

rinri@m.ehime-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 11 Month 08 Day

Date of IRB

2023 Year 11 Month 13 Day

Anticipated trial start date

2023 Year 12 Month 01 Day

Last follow-up date

2024 Year 11 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 11 Month 30 Day


Other

Other related information

A cohort study using health insurance claim databases


Management information

Registered date

2023 Year 11 Month 22 Day

Last modified on

2023 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060332


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name